These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 7154512)
1. [Effect of cordaron on the threshold of ventricular fibrillation in cats]. Stoliarchuk AA; Storozhuk BG Kardiologiia; 1982 Nov; 22(11):82-4. PubMed ID: 7154512 [TBL] [Abstract][Full Text] [Related]
2. [Effect of amiodarone on stimulatory convertibility and degeneration into ventricular fibrillation of induced ventricular tachycardias in the pig]. Hottinger S; Mettler D; Leupi F; Gertsch M Schweiz Med Wochenschr; 1985 Nov; 115(45):1594-6. PubMed ID: 4081686 [TBL] [Abstract][Full Text] [Related]
3. [Experience with the clinical study of cordaron]. Khalfen ESh; Shvarts IL; Shigin IuN; Klochkov VA; Temkin BM Kardiologiia; 1980 Oct; 20(10):45-9. PubMed ID: 7003190 [TBL] [Abstract][Full Text] [Related]
4. [Antifibrillatory activity of anti-arrhythmia agents in maximally high ligation of the coronary artery and its reperfusion in cats]. Storozhuk BG Farmakol Toksikol; 1985; 48(3):47-9. PubMed ID: 4029380 [TBL] [Abstract][Full Text] [Related]
5. [Effect of previous administration of amiodarone on the early incidence of ventricular fibrillation during experimental myocardial ischemia]. Spadaro J; Hashimoto LM; Franco RS; Bregagnollo EA; Tucci PJ Arq Bras Cardiol; 1984 Jan; 42(1):25-9. PubMed ID: 6743037 [No Abstract] [Full Text] [Related]
6. [Study of the effectiveness of cordaron in different types of arrhythmia]. Zakharov VN; Kuznetsov KK Kardiologiia; 1977 Apr; 17(4):90-3. PubMed ID: 69743 [TBL] [Abstract][Full Text] [Related]
7. [Comparative characteristics of the experimental antifibrillatory action of anti-arrhythmia preparations]. Storozhuk BG; Stoliarchuk AA Farmakol Toksikol; 1980; 43(5):579-81. PubMed ID: 7449988 [TBL] [Abstract][Full Text] [Related]
8. [Effects of sophoramine on ventricular fibrillation threshold and dispersion of refractoriness in cats]. Chen XS; Long YD; Yao LY; Luo W; Wu QH; Xiao LM; Zhang JM Zhongguo Yao Li Xue Bao; 1988 Nov; 9(6):551-4. PubMed ID: 3256220 [No Abstract] [Full Text] [Related]
9. [Cordaron in the treatment of patients with paroxysmal rhythm disorders]. Kiseleva LN; Nekrasova LF Vrach Delo; 1986 Mar; (3):28-31. PubMed ID: 2424177 [No Abstract] [Full Text] [Related]
10. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study. Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH; Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672 [TBL] [Abstract][Full Text] [Related]
11. Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT). Crystal E; Kahn S; Roberts R; Thorpe K; Gent M; Cairns JA; Dorian P; Connolly SJ J Thorac Cardiovasc Surg; 2003 Mar; 125(3):633-7. PubMed ID: 12658206 [TBL] [Abstract][Full Text] [Related]
19. Defibrillation threshold testing in implantable cardioverter-defibrillators: might less be more than enough? Curtis AB J Am Coll Cardiol; 2008 Aug; 52(7):557-8. PubMed ID: 18687250 [No Abstract] [Full Text] [Related]